Assessing susceptibility to autoimmune (type 1) diabetes mellitus and related endocrine disorders. Distinguishing between type 1 and type 2 diabetes. Confirming diagnosis of stiff-man syndrome and related autoimmune encephalomyelopathies.
< or = 0.02 nmol/L
* Reference ranges may change over time. Please refer to the original patient report when evaluating results.
3 - 8 days
- GAD (Glutamic Acid Decarboxylase) Antibody
- Islet Cell Cytoplasmic Antibody
- Stiffman Syndrome
- GAD65 Ab Assay, CSF
- GAD CSF
Collect spinal fluid; refrigerate.
Test sent to Mayo Medical Laboratories.